Table 4 Least square means analysis of follow-up findings, adjusted for baseline values
From: Long-term cardiac pathology in individuals with mild initial COVID-19 illness
Symptom status (baseline/follow-up) | Sym/Sym | Sym/Asym | Asym/Sym | Asym/Asym | P value |
|---|---|---|---|---|---|
n = 182 | n = 70 | n = 16 | n = 78 | ||
Heart rate (bpm) | 68.2 (66.8–69.5) | 65.8 (63.6–67.9) | 67.7 (63.2–72.2) | 67.2 (65.1–69.3) | 0.31 |
Systolic BP (mmHg) | 127 (125–129) | 127 (123–130) | 130 (123–137) | 132 (129–135) | 0.04 |
LVEF (%) | 57.0 (56.4–57.5) | 56.6 (55.7–57.5) | 57.6 (55.7–59.5) | 57.0 (56.2–57.9) | 0.8 |
GLS (%) | –18.9 (−19.6 to −18.2) | −18.5 (−19.8 to −17.3) | −19.9 (−22.3 to −17.4) | −19.2 (−20.4 to −18.0) | 0.75 |
LV-EDVi (ml m−2) | 84.0 (82.7–85.2) | 84.1 (82.1–86.1) | 87.4 (83.3–91.5) | 86.4 (84.5–88.3) | 0.10 |
LV mass index (g m−2) | 46.5 (45.3–47.7) | 47.9 (46.0–49.8) | 48.0 (44.0–51.9) | 48.7 (46.9–50.5) | 0.22 |
RVEF (%) | 55.9 (55.2–56.7) | 54.3 (53.1–55.5) | 56.0 (53.5–58.4) | 55.1 (53.9–56.2) | 0.14 |
Native T1 (ms) | 1,124 (1,121–1,127) | 1,119 (1,114–1,124) | 1,119 (1,107–1,129) | 1,119 (1,114–1,124) | 0.27 |
Native T2 (ms) | 37.9 (37.7–38.0) | 37.4 (37.2–37.7) | 38.0 (37.5–38.5) | 37.5 (37.3–37.8) | 0.01 |
